Determination of rifabutin in human plasma by high-performance liquid chromatography with ultraviolet detection.
A simple, specific and sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of rifabutin in human plasma. Rifabutin and sulindac (internal standard) are extracted from human plasma using a C8 Bond Elut extraction column. Methanol (1 ml) is used to elute the compounds. The methanol is dried down under nitrogen and reconstituted in 250 microliters of mobile phase. Separation is achieved by HPLC on a Zorbax Rx C8 column with a mobile phase composed of 0.05 M potassium dihydrogen phosphate and 0.05 M sodium acetate at pH 4.0-acetonitrile (53:47, v/v). Detection is by ultraviolet absorbance at 275 nm. The retention times of rifabutin and internal standard were approximately 10.8 and 6.9 min, respectively. The assay is linear over the concentration range of 5-600 ng/ml. The quantitation limit was 5 ng/ml. Both intra-day and inter-day accuracy and precision data showed good reproducibility.
Lau
Y Y
YY
Department of Biopharmaceutics, Corning Hazleton Inc., Madison, WI 53704, USA.
Hanson
G D
GD
Carel
B J
BJ
D000900:Anti-Bacterial Agents / Q000097:blood* / Q000493:pharmacokinetics; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D011786:Quality Control; D017828:Rifabutin / Q000097:blood* / Q000493:pharmacokinetics; D012996:Solutions; D013056:Spectrophotometry, Ultraviolet
D000900:Anti-Bacterial Agents; D012996:Solutions; D017828:Rifabutin